CHK1 affects cell sensitivity to microtubule-targeted drugs

Journal of Cellular Physiology

Volumn 203, Issue 1, 2005, Pages 273-276

  Ren, Qing ^a   Liu, Ronghua ^a   Dicker, Adam ^a   Wang, Ya ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; DOCETAXEL; NOCODAZOLE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; FIBROBLAST; MICROTUBULE ASSEMBLY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TRANSFORMED; DRUG RESISTANCE, NEOPLASM; FIBROBLASTS; MICROTUBULES; MITOCHONDRIA; NOCODAZOLE; PROTEIN KINASES; RATS; RNA, SMALL INTERFERING; TAXOIDS;

MAMMALIA;

EID: 14744274758     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20222     Document Type: Article

References (13)

1. Alli E, Bash-Babula J, Yang J-M, Hait WN. 2002. Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res 62(23):6864-6869.
2. Brown EJ, Baltimore D. 2000. ATR disruption leads to chromosomal fragmentation and early embryonic lethality. Genes Dev 14(4):397-402.
3. Galmarini CM, Kamath K, Vanier-Viornery A, Hervieu V, Peiller E, Falette N, Puisieux A, Ann Jordan M, Dumontet C. 2003. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics. Br J Cancer 88:1793-1799.
4. Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M, Altieri DC. 2002. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 62(9):2462-2467.
5. Hu B, Zhou XY, Wang X, Zeng ZC, Iliakis G, Wang Y. 2001. The radioresistance to killing of A 1-5 cells derives from activation of the Chk1 pathway. J Biol Chem 276:17693-17698.
6. Hu B, Han S-Y, Wang X, Ottey M, Potoczek MB, Dicker A, Huebner K, Wang Y. 2004. Involvement of the Fhit gene in the ionizing radiation-activated ATR/ CHK1 pathway. J Cell Phys. DOI 10.1002/jcp.20139.
7. Jordan MA, Wilson L. 2004. Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253-265.
8. Kaneko Y, Watanabe N, Morisaki H, Akita H, Fujimoto A, Tominaga K, Tachibana K, Ikeda K, Nakanishi M. 1999. Cell cycle-dependent and ATM-independent expression of human Chk1 kinase. Oncogene 18:3673-3681.
9. Liu Q, Guntuku S, Cui XS, Matsuoka S, Cortez D, Tamai K, Luo G, Carattini-Rivera S, DeMayo F, Bradley A, Donehower LA, Elledge SJ. 2000. Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint. Genes Dev 14:1448-1459.
10. Martinez J, Georgoff I, Martinez J, Levine AJ. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev 5:151-159.
11. Takai H, Tominaga K, Motoyama N, Minamishima YA, Nagahama H, Tsukiyama T, Ikeda K, Nakayama K, Nakanishi M, Nakayama K. 2000. Aberrant cell cycle checkpoint function and early embryonic death in Chk1(-/-) mice. Genes Dev 14(12):1439-1447.
12. Wang J-L, Wang X, Wang H, Iliakis G, Wang Y. 2002. CHK1-regulated S-phase checkpoint response reduces camptothecin cytotoxicity. Cell Cycle 1:267-272.
13. Warterman SC, Salmon ED. 1997. Microtubule dynamics: Treadmiling corners again. Curr Biol 7:369-372.